[1] Li H, Wang S, Wang G, et al. Yes-associated protein expression is a predictive marker for recurrence of hepatocellular carcinoma after liver transplantation. Dig Surg,2014,31:468-478. [2] El-Serag HB,Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology,2007, 132:2557-2576. [3] Reis H, Pütter C, Megger DA, et al. A structured proteomic approach identifies 14-3-3Sigma as a novel and reliable protein biomarker in panel based differential diagnostics of liver tumors. Biochim Biophys Acta,2015,1854:641-650. [4] Tawada A, Kanda T, Yokosuka O. Current and future directions for treating hepatitis B virus infection. World J Hepatol,2015, 7:1541-1552. [5] Park YN. Update on precursor and early lesions of hepatocellular carcinomas. Arch Pathol Lab Med, 2011, 135: 704-715. [6] Gehrmann M, Cervello M, Montalto G, et al. Heat shock protein 70 serum levels differ significantly in patients with chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. Front Immunol,2014,5:307. [7] 冯龙海,董辉,朱玉瑶,等. Hsp70、GPC3、GS 和AKR1B10 在肝脏高度异型增生结节免疫组化诊断中的应用.临床与实验病理学杂志,2016,32:601-605. [8] 邹柯涵,徐敏,罗书笛,等. CK、Ki67、Gly-3 及P53 在肝细胞癌组织中的表达.湖南中医药大学学报,2017,37:326-328. [9] 郭晓东, 熊璐,曹晨,等. 抑癌基因p53 在肝癌组织中的异常表达及临床意义. 现代生物医学进展,2012,12:66-68. |